Arsenic trioxide for treatment of PIN1-associated disorders
US10980835B2 · kind B2 · utility
0Cited by
4References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2017 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Dec 1, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the treatment of Pin1-associated disorders (e.g., disorders characterized by elevated Pin1 activity) with arsenic trioxide, optionally in combination with a retinoic acid compound. Pin1-associated disorders may include, for example, proliferative disorders (e.g., cancers), inflammatory conditions, and autoimmune disorders associated with aberrant levels of Pin1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.